Biocon gets EIR from USFDA for Bengaluru biologics unit Medical Dialogues Bureau6 Nov 2019 3:49 AMNew Delhi: Biopharmaceutical firm Biocon on Tuesday said it has received an establishment inspection report (EIR) from the US health regulator for its...
Lupin to lays off employees from RnD Divsion Farhat Nasim15 March 2019 12:31 PMMumbai: Facing a Setback in its business turf, one the largest manufacturers of medicines in the country Lupin Ltd is taking steps to rationalize its...
Aurobindo looks for inorganic growth prospects in East Europe Ruby Khatun Khatun27 Nov 2017 5:10 AMMumbai: Hyderabad-based Aurobindo Pharma is looking at inorganic growth opportunities in Eastern Europe and other geographies for deeper market...
Mylan seeks EMA approval for 2 biosimilars Ruby Khatun Khatun9 Nov 2017 5:02 AMNew Delhi: Biocon said that its partner Mylan has re-submitted marketing authorization applications with the European Medicines Agency for two...
Biocon aspiring for 1 billion dollar revenues by FY19 Ruby Khatun Khatun11 Sept 2017 4:52 AMNew Delhi: Biocon is betting big on small molecules and generic formulations, biosimilars, branded formulations and research services as it targets $1...
Europe ready to embrace first copies of biotech cancer drugs supriya kashyap kashyap17 Feb 2017 6:55 AMLondon : Treatment with two important cancer drugs is about to get much cheaper in Europe with a cut-price copy of Roche's blood cancer drug Rituxan...
